Consistent with its role as a tumor suppressor, azacitidine-mediated demethylation of the p16INK4a locus significantly increased expression of p16INK4a and inhibited the growth of ATLL cells [55]. The gene discussed is CDKN2A; the disease is adult T-cell leukemia/lymphoma.